Skip Navigation

European Heart Journal 1992 13(12):1632-1636;
Copyright © 1992 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by BRIDGES, A. B.
Right arrow Articles by BELCH, J. J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRIDGES, A. B.
Right arrow Articles by BELCH, J. J. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 The European Society of Cardiology

Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease

A. B. BRIDGES*,, N. A. SCOTT*, G. P. MCNEILL{dagger}, T. H. PRINGLE{dagger} and J. J. F. BELCH*

*University Departments of Medicine Ninewells Hospital and Medical School Dundee DD1 9S Y, Scotland, U.K.
{dagger}Cardiology, Ninewells Hospital and Medical School Dundee DD1 9S Y, Scotland, U.K.

Received 23 December 1991; revised 10 July 1992; .

Correspondence Dr A B Bridges, University Department of Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, U.K.

Abstract

The fibrinolytic activity of blood has a circadian variation with increased thrombotic tendency in the morning. This may be a contributory factor to the circadian variation in the time of onset of thrombotic events. However, there has recently been increasing interest to the role of the white blood cells (WBC)and free radicals (FRs) in thrombosis. We have previously reported a circadian variation in WBC aggregation and FR status in normal volunteers. No one has yet studied possible circadian variations in these parameters in patients with stable ischaemic heart disease (IHD).

Ten men with stable IHD had blood samples collected at four-hourly intervals from midday until midday the following day. The patients were ambulant until midnight at which time they went to bed and remained in bed until 0800 h. The following were measured on each sample: WBC aggregation, malondialdehvde (MDA) which is a product of lipid peroxidation by FRs; the FR scavengers, plasma thiol (PSH), red cell glutathione (GSH) and superoxide dismutase (SOD) which are all altered in the presence of increased FR activity. WBC aggregation and PSH had significant circadian variations, P < 0·015 and P<0·001 respectively. The WBC aggregation peak was at 1200 h and trough at 1600 h, the PSH peak was at midnight and the trough at 0400 h.

WBC behaviour and FR status influence the flow properties of blood. The largest rise in WBC aggregation occurredfrom 0800 h to 1200 h; such an increase in aggregation could predispose to microcirculatory occlusion. The level of the scavenger PSH was lowest at 0400 h; at this time FR products, as measured by MDA in the IHD patients, did not fall. This is in contrast to normal volunteers. This combination of low level of plasma scavenger and a relatively raised MDA level may predispose to thrombosis at this time.

Key Words: Circadian rhythm • leukocyte • free radicals • atherosclerosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Circulation, December 5, 2006; 114(23): 2508 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. A.J. Farquharson, R. Butler, A. Hill, J. J.F. Belch, and A. D. Struthers
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Circulation, July 9, 2002; 106(2): 221 - 226.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. Butler, A. D. Morris, J. J. F. Belch, A. Hill, and A. D. Struthers
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Hypertension, March 1, 2000; 35(3): 746 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Schrammel, S. Pfeiffer, K. Schmidt, D. Koesling, and B. Mayer
Activation of Soluble Guanylyl Cyclase by the Nitrovasodilator 3-Morpholinosydnonimine Involves Formation of S-Nitrosoglutathione
Mol. Pharmacol., July 1, 1998; 54(1): 207 - 212.
[Abstract] [Full Text]

Home page
 CirculationHome page
D. J. Patel, C. J. Knight, D. R. Holdright, D. Mulcahy, D. Clarke, C. Wright, H. Purcell, and K. M. Fox
Pathophysiology of Transient Myocardial Ischemia in Acute Coronary Syndromes: Characterization by Continuous ST-Segment Monitoring
Circulation, March 4, 1997; 95(5): 1185 - 1192.
[Abstract] [Full Text]

Home page
 CirculationHome page
E. Braunwald
Morning Resistance to Thrombolytic Therapy
Circulation, March 1, 1995; 91(5): 1604 - 1606.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.